Brief: Sorrento Therapeutics Inc - On Feb 21, Co Requested Appeal Of Nasdaq's Determination And Hearing Before A Nasdaq Hearings Panel
Feb 21 (Reuters) - Sorrento Therapeutics Inc SRNE.O :
* SORRENTO THERAPEUTICS INC - ON FEB 21, CO REQUESTED APPEAL
OF
NASDAQ'S DETERMINATION AND HEARING BEFORE A NASDAQ HEARINGS
PANEL
Further company coverage: SRNE.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sorrento Therapeutics
See all newsBrief: Scilex Holding Says US Bankruptcy Court Extended Lockup Period On Shares Of Scilex Stock
Company's PO box allows it to file for bankruptcy in Texas, judge rules
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute (updated)
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute
Brief: Sorrento Therapeutics Reduced U.S. Headcount From 215 To 128 on Sept. 20